Learn More
Medchemexpress LLC BI-847325 | 1207293-36-4 | 98.15% | 464.56 | 50 MG

Supplier: Medchemexpress LLC HY1895550MG
BI-847325 is an ATP competitive dual inhibitor of MEK and aurora kinases (AK). It inhibits the growth and survival of both treatment-naive and drug-resistant melanoma cell lines, decreasing the expression of MEK and Mcl-1 while increasing the expression of pro-apoptotic protein Bim. This compound is also a click chemistry reagent, containing an Alkyne group that can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
- ATP competitive dual inhibitor of MEK and aurora kinases
- Inhibits MEK2 with an IC50 of 4 nM
- Inhibits aurora kinases with IC50 values of 15 nM for AK-C and 25 nM for AK-A
- Inhibits LCK (5 nM) and MAP3K8 (93 nM) at 1,000 nM
- Induces apoptosis in treatment-naive and drug-resistant xenografted melanoma in vivo
- Click chemistry reagent with an Alkyne group
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.